文献速递急性肾损伤慢性肾脏病

AL型淀粉样变性自体干细胞移植期间急性肾损伤的预测因素与结局

Predictors and outcomes of acute kidney injury during autologous stem cell transplantation in AL amyloidosis.
PubMed 文献 · Nephrol Dial Transplant · 2022-01-01

该观察性研究纳入223例接受HDM/SCT的AL型淀粉样变性患者,AKI发生率为29.1%,中位随访4.5年。AKI与全因死亡风险(HR=4.53)和ESKD风险(HR=4.6)增加相关,并建立了基于eGFR<60、室间隔厚度>12 mm和白蛋白<3 g/dL的预测模型(AUC=0.8)。

要点

  • HDM/SCT后30天内AKI发生率为29.1%,多发生在最初2周内。
  • AKI与全因死亡(HR=4.53)和ESKD(HR=4.6)风险增加独立相关。
  • 基于eGFR<60、IVSd>12 mm、白蛋白<3 g/dL的模型可预测AKI(AUC=0.8)。

核心结论

  • AKI在AL型淀粉样变性患者HDM/SCT后常见,并导致ESKD和死亡风险增加。
  • 基于三个常规变量的预测模型有助于临床决策。

研究设计与样本

  • 观察性研究,纳入223例接受HDM/SCT的AL型淀粉样变性患者。
  • AKI定义为HDM/SCT后30天内血清肌酐升至基线≥1.5倍。

主要发现

  • 中位年龄58岁(范围30-77),肾脏和心脏受累分别占86.1%和56.8%。
  • AKI发生率为29.1%,15例(6.7%)开始透析,其中12例(80%)脱离透析。
  • 中位随访4.5年(范围0.1-16.5),AKI与全因死亡风险增加相关(HR=4.53,95%CI 2-10.23)。
  • 10年总生存率无AKI为87.1%,有AKI为56.9%。
  • AKI与ESKD风险增加相关(HR=4.6,95%CI 1.44-14.38),10年ESKD风险有AKI为18.9%,无AKI为8.1%。

关键数值与推荐

  • 多因素logistic回归模型纳入eGFR<60 mL/min/1.73 m2、室间隔舒张期厚度>12 mm和白蛋白<3 g/dL。
  • 该模型预测AKI的AUC为0.8。

临床怎么用

  • 对于拟行HDM/SCT的AL型淀粉样变性患者,可使用eGFR、室间隔厚度和白蛋白进行AKI风险分层。
  • 移植后早期(尤其前2周)应密切监测肾功能,及时识别AKI。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Acute kidney injury (AKI) is a common complication after high-dose melphalan and autologous stem cell transplantation (HDM/SCT) in patients with light chain (AL) amyloidosis. However, its incidence, predictors and outcomes are not well known. METHODS: This observational study included 223 patients with AL amyloidosis who underwent HDM/SCT. AKI was defined as an increase in serum creatinine to ≥1.5 times the baseline occurring within the first 30 days of HDM/SCT. RESULTS: The median age was 58 years (range: 30-77). Kidney and cardiac involvement were present in 86.1% and 56.8%, respectively. The median estimated glomerular filtration rate (eGFR) was 83.5 mL/min/1.73 m2 (range: 9-213) and proteinuria was 2899 mg/day (range: 0-19 966). AKI occurred in 29.1% of patients. Dialysis was initiated in 15 patients (6.7%) and of these 12 (80%) were able to discontinue dialysis. Most of the episodes of AKI occurred within the first 2 weeks; with a median follow-up of 4.5 years (range: 0.1-16.5), AKI was associated with increased overall mortality [hazard rato (HR) = 4.53, 95% confidence interval (CI) 2-10.23]. The 10-year overall survival was 87.1% without AKI, versus 56.9% with AKI. AKI was also associated with an increased risk for end-stage kidney disease (ESKD) (HR = 4.6, 95% CI 1.44-14.38). The risk of developing ESKD at 10 years was 18.9% with AKI, versus 8.1% without AKI. Several risk factors were found and using multivariate logistic regression, a prediction model was developed that included three readily available variables: eGFR <60 mL/min/1.73 m2, interventricular septal thickness in diastole >12 mm and albumin <3 g/dL. This model was able to predict AKI development with an area under the curve of 0.8. CONCLUSIONS: AKI is common in the post-HDM/SCT period and it leads to increased risk for ESKD and death. Our prediction model is an easily deployable tool in clinical settings as part of the discussion with patients who are being prepared for HDM/SCT.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Nader R, Zhen A, Angel-Korman A, et al. Predictors and outcomes of acute kidney injury during autologous stem cell transplantation in AL amyloidosis. Nephrol Dial Transplant. 2022. PMID: 34043009. doi:10.1093/ndt/gfab189

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。